1-(3-Chlorophenyl)-3-(5-(2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl)thiazol-2-yl)urea

Catalog No. :
ACGDYT412
CAS No. :
1057249-41-8
Molecular Formula :
C18H15ClN6OS2
Molecular Weight :
430.95

IUPAC Name:SNS-314

1-(3-Chlorophenyl)-3-(5-(2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl)thiazol-2-yl)urea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$310.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Chlorophenyl)-3-(5-(2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl)thiazol-2-yl)urea
IUPAC NameSNS-314
Molecular FormulaC18H15ClN6OS2
Molecular Weight430.95
SMILESO=C(NC1=NC=C(CCNC2=C3C(C=CS3)=NC=N2)S1)NC4=CC=CC(Cl)=C4
InChI KeyFAYAUAZLLLJJGH-UHFFFAOYSA-N
Synonym802IFJ0Z8X | SNS314 | UNII-802IFJ0Z8X | N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea. | 1-(3-chlorophenyl)-3-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl]urea | SNS-314 free base | NS 314
CAS No.1057249-41-8
PubChem CID24995524

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACGDYT412 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGDYT412 route product structure diagram
    ACGDYT4121057249-41-8
Inquiry

2. ACGDYT412 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKXUP612 route compound structure diagram
    ACKXUP61216269-66-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGDYT412 route product structure diagram
    ACGDYT4121057249-41-8
Inquiry

Comments (0)